Development of a pediatric physiologically-based pharmacokinetic model to support recommended dosing of atezolizumab in children with solid tumors

Background: Atezolizumab has been studied in multiple indications for both pediatric and adult patient populations. Generally, clinical studies enrolling pediatric patients may not collect sufficient pharmacokinetic data to characterize the drug exposure and disposition because of operational, ethic...

Full description

Bibliographic Details

Published in:	Frontiers in Pharmacology
Main Authors:	Weize Huang, Felix Stader, Phyllis Chan, Colby S. Shemesh, Yuan Chen, Katherine L. Gill, Hannah M. Jones, Linzhong Li, Gianluca Rossato, Benjamin Wu, Jin Y. Jin, Pascal Chanu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Subjects:	alveolar soft part sarcoma atezolizumab physiologically-based pharmacokinetic (PBPK) modeling pediatric extrapolation pediatric oncology solid tumor
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.974423/full